Valuation: BioElectronics Corporation

Market Cap 12.35M 10.8M 9.92M 9.25M 17.55M 1.18B 17.81M 119M 46.31M 578M 46.37M 45.37M 1.99B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.46M 20.64M 19.24M 36.5M 2.45B 37.05M 248M 96.34M 1.2B 96.45M 94.37M 4.14B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month-25.00%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.000265
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 2019-11-14
Sales & Marketing - 2017-08-31
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 2020-06-14
Director/Board Member - 2019-11-14
Director/Board Member - 2024-12-02
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-50.00% 7.41M
+1.97%+2.03%+21.92%+0.55% 195B
+5.87%+5.27%-21.76%+27.59% 151B
+2.17%+0.89%-2.59%-16.62% 140B
+4.83%+2.06%-56.73%-15.23% 67.09B
+2.59%+3.95%+22.89%+3.75% 54.34B
+0.03%+2.19%-25.17%-30.62% 44.63B
+0.31%+1.30%+8.30%+42.29% 37.24B
-2.02%-3.91%+7.67%+9.36% 36.91B
+4.24%+4.66%-18.42%-3.15% 30.24B
Average +2.00%+2.47%-1.39%-3.21% 75.59B
Weighted average by Cap. +2.78%+3.44%-4.01%+2.09%

Financials

2020 2021
Net sales 830K 725K 666K 621K 1.18M 78.99M 1.2M 8M 3.11M 38.83M 3.11M 3.05M 134M 1.61M 1.41M 1.29M 1.21M 2.29M 153M 2.32M 15.52M 6.03M 75.33M 6.04M 5.91M 260M
Net income -1.16M -1.01M -932K -868K -1.65M -110M -1.67M -11.19M -4.35M -54.28M -4.35M -4.26M -187M -290K -253K -233K -217K -412K -27.6M -418K -2.8M -1.09M -13.56M -1.09M -1.06M -46.74M
Net Debt 13.07M 11.42M 10.5M 9.79M 18.56M 1.24B 18.84M 126M 49M 612M 49.05M 48M 2.11B 13.34M 11.66M 10.72M 9.99M 18.95M 1.27B 19.24M 129M 50.02M 624M 50.08M 49M 2.15B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
26-07-02 US$0.000300 0.00% 2,540,317
26-07-01 US$0.000300 0.00% 19,876,498
26-06-30 US$0.000300 +20.00% 9,358,333
26-06-29 US$0.000250 0.00% 6,930,833
  1. Stock Market
  2. Stocks
  3. BIEL Stock